Quick Answer
BIO-RAD LABORATORIES, INC. reported Total Assets of $10.58 billion for the year ending 2025.
- BIO-RAD LABORATORIES, INC. showed an increase of +12.9% in Total Assets from 2024 to 2025.
- This data is from BIO-RAD LABORATORIES, INC.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $2.53 billion | Q3 2010: $2.68 billion | Q1 2011: $2.91 billion | Q2 2011: $3.04 billion | Q3 2011: $2.97 billion | Q1 2012: $3.19 billion | Q2 2012: $3.17 billion | Q3 2012: $3.30 billion | Q1 2013: $3.46 billion | Q2 2013: $3.48 billion | Q3 2013: $3.28 billion | Q1 2014: $3.44 billion | Q2 2014: $3.47 billion | Q3 2014: $3.39 billion | Q1 2015: $3.33 billion | Q2 2015: $3.53 billion | Q3 2015: $3.67 billion | Q1 2016: $3.75 billion | Q2 2016: $3.87 billion | Q3 2016: $4.02 billion | Q1 2017: $3.95 billion | Q2 2017: $4.14 billion | Q3 2017: $4.19 billion | Q1 2018: $6.21 billion | Q2 2018: $6.39 billion | Q3 2018: $6.72 billion | Q1 2019: $6.86 billion | Q2 2019: $7.65 billion | Q3 2019: $7.18 billion | Q1 2020: $8.68 billion | Q2 2020: $10.10 billion | Q3 2020: $12.02 billion | Q1 2021: $13.93 billion | Q2 2021: $15.12 billion | Q3 2021: $19.95 billion | Q1 2022: $14.37 billion | Q2 2022: $12.68 billion | Q3 2022: $12.06 billion | Q1 2023: $13.67 billion | Q2 2023: $11.98 billion | Q3 2023: $11.90 billion | Q1 2024: $12.61 billion | Q2 2024: $9.69 billion | Q3 2024: $10.60 billion | Q1 2025: $9.53 billion | Q2 2025: $10.21 billion | Q3 2025: $9.70 billion.
- Over the full 17 years of available data (2009 to 2025), BIO-RAD LABORATORIES, INC.'s Total Assets has grown by 317.1%.
- Historical annual values: Fiscal year 2025: $10.58 billion | Fiscal year 2024: $9.36 billion | Fiscal year 2023: $12.30 billion | Fiscal year 2022: $13.50 billion | Fiscal year 2021: $17.80 billion | Fiscal year 2020: $12.97 billion | Fiscal year 2019: $8.01 billion | Fiscal year 2018: $5.61 billion | Fiscal year 2017: $4.27 billion | Fiscal year 2016: $3.85 billion | Fiscal year 2015: $3.71 billion | Fiscal year 2014: $3.34 billion | Fiscal year 2013: $3.39 billion | Fiscal year 2012: $3.44 billion | Fiscal year 2011: $3.10 billion | Fiscal year 2010: $3.06 billion | Fiscal year 2009: $2.54 billion.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: